November 16, 2018
Rose
Patrick O’Connor wants his group -- the Alliance to Protect Medical Innovation -- to be able to shine a light on pharmaceutical companies that he contends are taking big risks and developing innovative treatments to help patients. But he's facing a lot of skepticism. Meanwhile, cutting edge therapies are setting the health industry on fire, but their costs temper that excitement. In other pharmaceutical news: medication adherence, generics safety and more.
from Kaiser Health News https://ift.tt/2qNtapX
November 16, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Research Shows Improvement In Curbing Docs’ Post-Surgical Prescribing, But There’s Still A Long Way To Go- Doctors Suspect Vaping Is Linked To Dozens Of Lung Illnesses In Teens Who Had To Be Hospitalized
- Perspectives On Drug Costs: Fix The Drug Shortages ‘Game’
- Push To Hold Public Vote On Missouri’s Abortion Law Faces Uphill Climb
- FDA Approves Lifesaving Treatment For Drug-Resistant Tuberculosis, Hard-To-Cure Patients
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment